Machine Learning and Pregnancy Success Prediction in Fertility Treatments
Launched by IRCCS SAN RAFFAELE · Mar 18, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This is a multicentric, observational, retrospective, non-profit study, coordinated by the IRCCS San Raffaele Hospital, aims to analyze anonymized data collected between 2019 and 2024 from approximately 5,000 couples undergoing Assisted Reproductive Technology (ART) procedures across three participating centers. The study will examine key variables, including age, medical history, treatment protocols, ART techniques (such as In Vitro Fertilization \[IVF\] and Intracytoplasmic Sperm Injection \[ICSI\]), embryo quality, and pregnancy outcomes, to develop a machine learning-based predictive mo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who underwent ART procedures, including IVF and ICSI, between 2019 and 2024.
- • Women aged between 18 and 43 years.
- Exclusion Criteria:
- • Patiens with incomplete or missing data records that do not provide sufficient information for analysis.
- • women outside the 18 to 43 age range
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported